CDK2-IN-36
CDK2-IN-36 (compound1) is a CDK2 inhibitor with anticancer activity[1].
Product Specifications
CAS Number
[3054692-45-1]
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
COC1=NNC=C1NC2=NC=C3C(N([C@@H]4CCC[C@@H](O)C4)C(C35CC5)=O)=N2
Molecular Formula
C18H22N6O3
Molecular Weight
370.41
References & Citations
[1]BRINER, Karin, et al. CYCLIN-DEPENDENT KINASE (CDK2) INHIBITORS. Patent WO2024171094.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-170441/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LAA785Mu71-01 100 µL
Biotin-Linked Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
Ask
View Details LAA785Mu71-02 200 µL
Biotin-Linked Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
Ask
View Details 
LAA785Mu71-03 1 mL
Biotin-Linked Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
Ask
View Details GTR15110415 1 Vial
Lentiviral human PARP10 shRNA (UAS) - Lentiviral human PARP10 shRNA (UAS, iRFP) (100)
Ask
View Details 